Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806080 | SCV000946061 | pathogenic | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp240*) in the SLC4A11 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This nonsense change has been observed in an individual with congenital hereditary endothelial dystrophy (PMID: 17397048). Loss-of-function variants in SLC4A11 are known to be pathogenic (PMID: 17220209, 17679935). For these reasons, this variant has been classified as Pathogenic. |